Cramer’s lightning round: Celsius is a buy
- It's that time again! "Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.
Viking Therapeutics: "I'm a Lilly guy...To go up against Lilly is very, very hard."
Cava: "Cava feels like it has the possibility of being a Chipotle. So, even though I know it just had a big spike, I would not abandon it. I would just look to buy more if it came down."
Rubrik: "It's a good company, but the problem is, again, this market hates enterprise software."
Forward Air: "There's great consolidation happening in this industry."
Bristol Myers Squibb: "Bristol-Meyers has a good dividend, and it's going to take a long time for it to be able to come to fruition, all the things that they want to do. I think it is bottoming...But that doesn't necessarily make us all that excited."
Money Report
Sign up now for the CNBC Investing Club to follow Jim Cramer's every move in the market.
Disclaimer The CNBC Investing Club Charitable Trust holds shares of Eli Lilly.
Feeling out of the loop? We'll catch you up on the Chicago news you need to know. Sign up for the weekly Chicago Catch-Up newsletter.
Questions for Cramer?
Call Cramer: 1-800-743-CNBC
Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram
Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com
